Is Lenvatinib included in medical insurance? How much does it cost?

Lenvatinib is a targeted drug used to treat a variety of cancers, especially in the treatment of liver cancer, kidney cancer and some thyroid cancers. Lenvatinib is currently on the market in China and has been included in medical insurance, so domestic patients can purchase it through formal channels in hospitals or pharmacies. Prices may differ in different regions and pharmacies. The following will provide a detailed analysis of the price of lenvatinib to help patients understand the price situation and purchasing channels in different regions.

Lenvatinib has been approved for marketing in China and is included in the scope of medical insurance reimbursement. Currently in China, the common specification of lenvatinib is 4mg*30 tablets, and the price is approximately 3000 yuan. The specific price may vary depending on the region, the hospital's pricing policy and the medical insurance reimbursement ratio. When purchasing, patients can consult the local hospital pharmacy to understand the actual price after medical insurance reimbursement, so as to make a better choice. Generally speaking, the price after medical insurance coverage will be lower than that without medical insurance, so patients should pay attention to the medical insurance payment policy of drugs when purchasing.

In overseas markets, lenvatinib also has two versions: original drug and generic version. Taking the original drug as an example, the price of lenvatinib is relatively high. Taking the European market as an example, the price of original drugs is approximately 2000 RMB. This price may fluctuate due to market demand and different regions. Compared with domestic prices, the prices of overseas original drugs are slightly lower, but they are still more expensive than generic drugs. If patients plan to purchase original drugs from overseas, they may consider purchasing through formal channels to ensure the authenticity and quality of the drugs.

In addition to the original drug, lenvatinib also has generic drugs on the market in countries such as Laos and Bangladesh. The prices of these generic drugs are significantly lower than those of the original drugs, ranging from 400 to 900 RMB. Since these generic drugs are basically the same as the original drugs in terms of drug ingredients, they can also achieve similar effects in terms of efficacy and safety. The price of generic drugs is more affordable, especially for those patients with limited financial conditions, generic drugs are undoubtedly a more suitable choice. Patients can choose to purchase original drugs or generic drugs according to their own needs and financial status.

Reference materials:https://www.lenvima.com/